A randomised, double-blind, parallel-group trial to assess mercaptopurine versus placebo to prevent or delay recurrence of Crohn’s disease following surgical resection (TOPPIC)

Jack Satsangi, Nicholas A Kennedy, Craig Mowat, Ian Dr Arnott, Catriona Keerie, Stephanie Lewis, Holly Ennis

Research output: Book/ReportOther report

Fingerprint

Dive into the research topics of 'A randomised, double-blind, parallel-group trial to assess mercaptopurine versus placebo to prevent or delay recurrence of Crohn’s disease following surgical resection (TOPPIC)'. Together they form a unique fingerprint.

Medicine and Dentistry